<DOC>
	<DOCNO>NCT00479388</DOCNO>
	<brief_summary>This 12-Week clinical trial patient Primary hypercholesterolemia mixed dyslipidemia study effect ER niacin/laropiprant lipid .</brief_summary>
	<brief_title>Study Extended Release Niacin/Laropiprant Lipids ( 0524A-067 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Patients 18 80 year age Primary hypercholesterolemia mixed dyslipidemia Patients eligible study LDLC value within protocol specify range meet entry criterion Patient whose LDLC value within protocol specify range</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>